Comments
Panacea Biotec on Tuesday said its board has approved raising up to ₹864 crore for one-time settlement with its lenders and other purposes.
The company will raise the funds through issue of non- convertible debentures on a private placement basis, Panacea said in a regulatory filing.
The capital will be utilised for one-time settlement with the consortium of lenders and for the settlement of stretched payables, employees’ dues and for working capital requirements, among others, it added.
The board also approved demerger of the company’s real estate business with a few modifications to the scheme of arrangement approved by the board in September 2017.
The company has also convened an extraordinary general general meeting (EGM) on March 25, during which the shareholders will consider the company’s plans to raise up to ₹128 crore via issue of warrants on a preferential basis.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.